Resmed Inc’s recent filing unveils that its Chairman and CEO Farrell Michael J. unloaded Company’s shares for reported $1.25 million on Dec 08 ’25. In the deal valued at $251.41 per share,4,991 shares were sold. As a result of this transaction, Farrell Michael J. now holds 466,223 shares worth roughly $115.32 million.
Then, Farrell Michael J. bought 4,991 shares, generating $1,254,796 in total proceeds.
Before that, FARRELL PETER C sold 2,000 shares. Resmed Inc shares valued at $502,940 were divested by the Director at a price of $251.47 per share. As a result of the transaction, FARRELL PETER C now holds 68,773 shares, worth roughly $17.01 million.
Robert W. Baird downgraded its Resmed Inc [RMD] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Citigroup’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. CLSA also remained covering RMD and has increased its forecast on September 02, 2025 with a “an Outperform” recommendation from previously “Hold” rating. RBC Capital Mkts revised its rating on July 15, 2025. It rated RMD as “an Outperform” which previously was an “a Sector perform”.
Price Performance Review of RMD
On Tuesday, Resmed Inc [NYSE:RMD] saw its stock fall -2.26% to $247.34. Over the last five days, the stock has gained 0.33%. Resmed Inc shares have risen nearly 1.99% since the year began. Nevertheless, the stocks have risen 8.16% over the past one year. While a 52-week high of $293.81 was reached on 08/22/25, a 52-week low of $199.92 was recorded on 04/07/25.
Levels Of Support And Resistance For RMD Stock
The 24-hour chart illustrates a support level at 244.00, which if violated will result in even more drops to 240.66. On the upside, there is a resistance level at 250.30. A further resistance level may holdings at 253.26.
How much short interest is there in Resmed Inc?
A steep rise in short interest was recorded in Resmed Inc stocks on 2025-11-28, growing by 0.73 million shares to a total of 10.42 million shares. Yahoo Finance data shows the prior-month short interest on 2025-10-31 was 9.69 million shares. There was a rise of 6.98%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on March 19, 2025 when Morgan Stanley began covering the stock and recommended ‘”an Overweight”‘ rating along with a $280 price target.
